10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from __________ to ___________

Commission file number: 333-212055

THE POCKET SHOT COMPANY

(Exact name of registrant as specified in its charter)

Colorado	71-0942431
(State of Incorporation)	(IRS Employer ID Number)

32950 Inverness Dr., Evergreen, CO 80439

(Address of principal executive offices)

(303) 674-2622

(Registrant’s Telephone number)

(Former Address and phone of principal executive offices)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

Yes  [X] No  [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 for Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes  [X] No  [  ]

Indicate by check mark whether the registrant is a large accelerated file, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[  ]	Accelerated filer	[  ]
Non-accelerated filer	[  ]	Smaller reporting company	[  ]
(Do not check if a smaller reporting company)
Emerging growth company	[X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  [  ] No  [X]

Indicate the number of share outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of November 15, 2017, there were 6,458,657 shares of the registrant’s common stock issued and outstanding.

TABLE OF CONTENTS

		Page
	PART 1 – FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	2
	Condensed Balance Sheets – December 31, 2016 and September 30, 2017	2
	Condensed Statements of Operations - Three and Nine months ended September 30, 2017 and 2016	3
	Condensed Statements of Stockholder’s Equity – September 30, 2017	4
	Condensed Statements of Cash Flows – Nine months ended September 30, 2017 and 2016	5
	Notes to the Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 3.	Quantitative and Qualitative Disclosures About Market Risk – Not Applicable	14
Item 4.	Controls and Procedures	14
	PART II- OTHER INFORMATION
Item 1.	Legal Proceedings	15
Item 1A.	Risk Factors - Not Applicable	15
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	15
Item 3.	Defaults Upon Senior Securities – Not Applicable	15
Item 4.	Mine Safety Disclosure – Not Applicable	15
Item 5.	Other Information – Not Applicable	15
Item 6.	Exhibits	15
	Signatures	16

 1

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

THE POCKET SHOT COMPANY

Balance Sheets

	September 30, 2017			December 31, 2016
ASSETS
Current assets
Cash	$	41,496		$	51,965
Accounts receivable		4,545			1,454
Inventory		73,396			84,635
Total current assets		119,437			138,054
Fixed assets
Machinery & equipment		305,165			305,165
Accumulated depreciation		(246,138	)		(224,595	)
		59,027			80,570
	$	178,464		$	218,624
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	13,194		$	-
Royalty payable		5,077			3,276
Total current liabilities		18,271			3,276
Stockholders’ equity
Common stock, no par value, 6,458,657 shares issued and outstanding at September 30, 2017 and December 31, 2016		-			-
Additional paid-in capital		583,069			583,069
Retained deficit		(422,876	)		(367,721	)
		160,193			215,348
	$	178,464		$	218,624

See accompanying notes to the condensed unaudited financial statements.

 2

THE POCKET SHOT COMPANY

Income Statements

For The Three and Nine Months Ended September 30, 2017 and 2016

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2017			2016			2017			2016
Royalty income	$	24,673		$	20,412		$	62,114		$	72,485
Costs of sales		8,418			605			20,912			20,331
Gross margin		16,255			19,807			41,202			52,154
Operating expenses
Advertising and promotion		-			255			319			5,805
General and administrative expenses		31,477			18,592			69,483			67,800
Sales incentives		-			-			-			832
Travel and entertainment		755			2,949			5,012			7,826
Depreciation expense		7,169			8,225			21,543			17,670
Total costs and expenses		39,401			30,021			96,357			99,933
Net income (loss)	$	(23,146	)	$	(10,214	)	$	(55,155	)	$	(47,779	)

See accompanying notes to the condensed unaudited financial statements.

 3

The Pocket Shot Company

STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED December 31, 2015 and 2016 and NINE MONTHS ENDED September 30, 2017

	Common Stock				Additional Paid-In		Stockholders’			Total Stockholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance, December 31, 2013		5,668,657		-	$	497,500	$	(165,818	)	$	331,682
Net loss for year ended December 31, 2014								(68,778	)		(68,778	)
Balance, December 31, 2014		5,668,657		-	$	497,500	$	(234,596	)	$	262,904
Shares issued for cash		790,000		-		79,000					79,000
Net loss for year ended December 31, 2015								(54,213	)		(54,213	)
Balance, December 31, 2015		6,458,657		-	$	583,069	$	(288,809	)	$	294,260
Net loss for year ended December 31, 2016								(78,912	)		(78,912	)
Balance, December 31, 2016		6,458,657		-	$	583,069	$	(367,721	)	$	215,348
Net loss for nine months ended September 30, 2017								(55,155	)		(55,155	)
Balance, September 30, 2017		6,458,657		-	$	583,069	$	(422,876	)	$	160,193

See accompanying notes to the condensed unaudited financial statements.

 4

THE POCKET SHOT COMPANY

Statements of Cash Flows

For The Nine Months Ended September 30, 2017 and 2016

	2017			2016
Cash flows provided by operating activities:
Net loss	$	(55,155	)	$	(47,779	)
Changes in Operating Assets and Liabilities
Accounts Receivable		(3,091	)		11,930
Inventory		11,239			(7,804	)
Accounts payable		13,194			(1,958	)
Royalty payable		1,801			2,102
Depreciation		21,543			17,670
Net cash provided (used) by operating activities	$	(10,469	)	$	(25,839	)
Cash flows from investing activities:
Purchases of property and equipment		-			(83,169	)
Net cash used by investing activities		-			(83,169	)
Cash flows from financing activities
Issuance of Capital Stock for cash		-			-
Net cash provided by financing activities		-			-
Net increase (decrease) in cash	$	(10,469	)	$	(109,008	)
Cash, beginning of period		51,965			156,412
Cash end of period	$	41,496		$	47,404

See accompanying notes to the condensed unaudited financial statements.

 5

The Pocket Shot Company

Notes to Combined Financial Statements

September 30, 2017 and December 31, 2016

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

The Pocket Shot Company, formerly Pocket Shot, LLC, a Colorado limited liability company, was initially formed on April 18, 2004. Under a 351 Exchange Agreement, the members chose to contribute all of their membership interests in the LLC to The Pocket Shot Company, a Colorado corporation in exchange for shares of common stock of the corporation in accordance with the terms and provisions of the agreement. The effective date for the exchange was January 1, 2006. The Company has developed a plastic pouch for the packaging of alcohol under the trademarks Pocketshot and Pocket Shot. The Company collects royalty income from licensing the right to use the patent and the trademarks in connection with manufacturing, filling and packaging the pouches with alcohol and the distribution, sale and advertising of the products under the brand name.

The Company’s accounting year end is December 31.

Basis of Presentation

These financial statements are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles.

Management’s Representation of Interim Financial Statements

The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements at December 31, 2015 and December 31, 2016 as presented in the Company’s Registration statement on Form S-1 filed with the Securities and Exchange Commission.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative instruments and recorded debt discount, valuation of deferred tax assets and valuation of in-kind contribution of services and interest.

Cash and Cash Equivalents

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At September 30, 2017 and December 31, 2016, the Company cash equivalents totaled $41,496 and $51,965 respectively.

Accounts Receivable

We record accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the combined statements of operations. We calculate this allowance based on our history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and our relationships with, and the economic status of, our customers. As of December 31, 2015 and December 31, 2016, an allowance for estimated, uncollectible accounts was determined to be unnecessary.

 6

Inventory

Inventory is reported at the lower of cost or market on the first-in, first-out (FIFO) method. Our inventory is subject to obsolescence. Accordingly, quantities on hand are periodically monitored for items no longer being sold, which are written off. All inventory is stored at the manufacturer and maintained by them. Inventory consists of pouches, display and shipping boxes and no inventory is deemed obsolete.

Machinery and Equipment

Machinery and equipment is recorded at cost. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant machinery and equipment categories are as five years.

A summary of machinery and equipment as of September 30, 2017 and December 31, 2016, is as follows:

	2017			2016
Machinery and equipment	$	305,165		$	305,165
Less accumulated depreciation		(246,138	)		(224,595	)
	$	59,027		$	80,570

Depreciation expense for the nine months ended September 30, 2017 and 2016 was $21,543 and $17,670, respectively.

Cost of Sales

The costs associated with our royalty income are packaging, a royalty of $1.20 per case, and repair and maintenance costs of our filling machines.

Advertising and Promotion

This category includes costs of website design and maintenance and event sponsorships.

General and Administrative

This category includes costs of legal and accounting, telephone, office supplies, product samples, insurance, registration costs, and consulting expenses.

Travel and Entertainment

This category includes the costs of air travel, hotels, meals and reimbursed automotive expenses.

Net Loss per Share

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share”. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

Revenue Recognition

We recognize revenue when the four revenue recognition criteria are met, as follows:

● Persuasive evidence of an arrangement exists – our customary practice is to obtain written evidence, typically in the form of a sales contract or purchase order;

 7

● Delivery – when custody is transferred to our customers either upon shipment to or receipt at our customers’ locations, with no right of return or further obligations, such as installation;

● The price is fixed or determinable – prices are typically fixed at the time the order is placed and no price protections or variables are offered; and

● Collectability is reasonably assured – we typically work with businesses with which we have a long standing relationship, as well as monitoring and evaluating customers’ ability to pay.

Refunds and returns, which are minimal, are recorded as a reduction of revenue. Payments received by customers prior to our satisfying the above criteria are recorded as unearned income in the combined balance sheets.

Fair Value of Financial Instruments

The Company applies the accounting guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, “Fair Value Measurements”, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.

The guidance also establishes a fair value hierarchy for measurements of fair value as follows:

● Level 1 - quoted market prices in active markets for identical assets or liabilities.

● Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

● Level 3 - unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amount of the Company’s financial instruments approximates their fair value as of September 30, 2017 and December 31, 2016, due to the short-term nature of these instruments.

Recent Accounting Pronouncements

 8

All newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

NOTE 3 – RELATED PARTY TRANSACTION

Consulting services are provided by shareholders. For the nine months ended September 30, 2017 and 2016, fees for these services amounted to $0 and $24,000 respectively.

The board of directors has approved and granted Jarrold R. Bachmann an officer and shareholder, a $1.20 per case royalty on sales of Pocket Shot effective January 1, 2006. Royalty expense for the nine months ended September 30, 2017 and 2016 were $1,801 and $2,102 respectively.

NOTE 4 – STOCKHOLDERS’ DEFICIT

The company has authorized and issued 6,458,657 common shares with a par value of $0.00 as of September 30, 2017 and December 31, 2016.

Under a 351 Exchange Agreement effective January 1, 2006, the former members of Pocket Shot, LLC agreed to contribute all of their membership interests in the LLC to The Pocket Shot Company, a Colorado corporation, in exchange for 4,943,657 shares of common stock, no par value per share, of the corporation in accordance with the terms and provisions of the agreement. Upon approval of the board of directors, the corporation has subsequently issued 675,000 shares of common stock at $0.50 per share and warrants to purchase 675,000 shares of common stock for $1 per share. The warrants have expired unexercised.

On June, 22, 2009, the board of directors approved the issuance of 50,000 shares of common stock to Michael Grove in consideration of past services as the Corporation’s consulting accountant.

In September, 2015, the company issued 790,000 common shares with a par value of $0.00 in exchange for $79,000.

NOTE 5 – COMMITMENTS AND CONTINGENCIES

The Company has developed a plastic pouch for the packaging of alcohol under the marks Pocketshot and Pocket Shot. The Company (the Licensor) entered into an initial agreement dated August 10, 2005 with Frank-Lin Distillers, Ltd (the Licensee) to fill and package the Company’s product. The initial term of the agreement was for five years. The agreement automatically renews for succeeding terms of two years each unless either party has given a written notice of its election to terminate the agreement at least one hundred, eighty calendar days prior to the end of any initial or extended term.

 9

NOTE 6 – ROYALTY INCOME

Under the terms of an existing License agreement, the company receives Royalty income in exchange for the license to manufacture, fill and distribute the Company’s product, a plastic pouch for the packaging of alcohol. The Licensee is required to pay the Licensor a royalty per case as provided in the agreement. All royalties due to the Licensor shall accrue upon the sale of the products, regardless of the time of collection by the Licensee.

NOTE 7 – CONCENTRATION OF SALES AND SEGMENTED DISCLOSURE

For the nine months ended September 30, 2017 and the year ended December 31, 2016, the company’s revenue was generated in the form of royalty income from a single license agreement. The company has operated in a single business segment, licensing their product to customers in the United States.

NOTE 8 – WARRANTS

In August 2015, the Company offered 790,000 shares of common stock at $0.10 per share, which included 790,000 warrants (1-for-1) exercisable at $0.50 per share of common stock, all expired in August 2017 unexercised. A summary of warrant activity is as follows:

	September 30, 2017				December 31, 2016
	Shares		Exercise Price		Shares		Exercise Price
Outstanding, beginning of period		6,458,657		N/A		6,458,657		N/A
Warrants Issued		0		N/A		0		N/A
Warrants Exercised		0		N/A		0		N/A
Warrants Expired		6,458,657		N/A		0		N/A
Outstanding, end of period		0		N/A		6,458,657		N/A

The fair value of the Warrants, $6,569, has been determined using the Black Scholes model with the following assumptions: stock price of $0.10 based on current sales of stock for cash, an exercise price of $.50 based on the agreement, term of 2 years, volatility of 81% based on comparable public companies, annual rate of quarterly dividends of 0.0% and a discount rate of 0 .75 which resulted in a call option value of $0.01 per warrant.

NOTE 9 – SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the filing date of these financial statements and has disclosed that there are no such events that are material to the financial statements to be disclosed.

 10

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements and Associated Risks.

This form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may”, “will”, “expect”, “believe”, “anticipate”, “estimate, or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include but are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; technological advances and failure to successfully develop business relationships.

Based on our financial history since inception, our auditor has expressed substantial doubt as to our ability to continue as a going concern. As reflected in the accompanying financial statements, as of September 30, 2017, we had an accumulated deficit totaling $(422,876). This raises substantial doubts about our ability to continue as a going concern.

Plan of Operation

The Company was incorporated under the laws of the State of Colorado on December 7, 2005. Our company holds a patent and several trademarks related to the “Pocket Shot,” an innovative concept that provides the consumer with “grab & go” convenience. Alcoholic beverages have been packaged in attractive, user-friendly 50ml single serving bottle-shaped plastic stand-up pouch, and non-alcoholic energy drinks will be produced in the near future. They are easy to stow and use by pouring from a bottleneck spout, similar to a bottle, and are ideal for active lifestyles.

Our primary method of selling is through distributors using an agreement that provides a monthly royalty for us.

We had no operations prior to 2005. Though we had income in the nine months ended September 30, 2017, our operating expenses were more than our net income during those periods. We have minimal cash, several intangible assets which consist of our patent, trademarks, business plan, relationships, and contacts, and some tangible assets of inventory, equipment, and machinery. We are lacking liquidity and need cash infusions from investors or shareholders to provide capital, or loans from any sources, none of which have been arranged nor assured.

Results of Operations

For the Three Months Ended September 30, 2017

During the three months ended September 30, 2017, we recognized total revenues of $24,673 compared to $20,412 for the three months ended September 30, 2016. The increase of $4,261 was a result of an increase in sales of Pocket Shots. During the three months ended September 30, 2017, we recognized a gross margin of $16,255 compared to $19,807 during the three months ended September 30, 2016. The decrease of $3,552 was due to an increase in cost of sales. During the three months ended September 30, 2017, we recognized a net loss of $23,146 compared to a net loss of $10,214 during the three months ended September 30, 2016. The net loss increasing by $12,932 was mainly a result of increased operating expenses, including increased general and administrative expenses, for the quarter ended September 30, 2017.

For the Nine Months Ended September 30, 2017

For the nine months ended September 30, 2017, we had $62,114 in revenues compared to $72,485 for the same period one year earlier. For the nine months ended September 30, 2017, our total operating expenses were $96,357 as compared to $99,933 for the nine months ended September 30, 2016. For the nine months ended September 30, 2017 we incurred advertising and promotion expenses of $319 compared to $5,805 for the corresponding period in 2016. This decreased expense and a decrease in travel and entertainment expenses by $2,814 contributed to the lower total costs and expenses, even though the depreciation expenses increased from $17,670 for the nine months ended September 30, 2016 to $21,543 for the nine months ended September 30, 2017. For the nine months ended September 30, 2017, we incurred expenses of $69,483 for general and administrative expenses compared to $67,800 for the same period in 2016. For the nine months ended September 30, 2017, we provided sales incentives in the amount of $0 compared to $832 for the corresponding period in 2016. For the nine months ended September 30, 2017, we incurred $5,012 for travel expenses compared to $7,826 for the same period in 2016. The net effect of these changes, was a decrease in operating expenses of $3,576.

 11

Our auditor has expressed substantial doubt as to whether we will be able to continue to operate as a “going concern” due to the fact that the Company has an accumulated deficit of $(422,876) as of September 30, 2017, compared to an accumulated deficit of $(367,721) at December 31, 2016, and has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining the adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

Financing Activities

During the quarter ended September 30, 2017 the Company received $0 from subscription agreements or private placement offerings. The Company also received shareholder contributions in the amount of $0 in the nine months ended September 30, 2017.

We intend to seek additional funding through public or private financings to fund our operations through fiscal 2017 and beyond. However, if we are unable to raise additional capital when required or on acceptable terms, or achieve cash flow positive operations, we may have to significantly delay product development and scale back operations both of which may affect our ability to continue as a going concern.

Investing Activities

The Company had no investing activities for the three months ended September 30, 2017.

Liquidity and Capital Resources

For the Nine Months Ended September 30, 2017

At September 30, 2017, we have total current assets of $119,437 consisting of $41,496 in cash and cash equivalents, accounts receivables of $4,545 and inventory of $73,396. Current liabilities at September 30, 2017 were $18,271 and consisted of accounts payable of $13,194 and of a royalty payable to Mr. Bachmann for $5,077. At September 30, 2017, we had working capital of $101,166. During the nine months ended September 30, 2017, we used $10,469 in cash for our operating activities. The net loss of $55,155 for the period was partially offset by $11,239 in inventory, $13,194 in accounts payable, and $21,543 in depreciation. There were no financing activities for the nine months ended September 30,2017.

We do not currently have any consulting agreements.

We do not currently have any outstanding debts, including promissory notes or other bank debt.

As at September 30, 2017, our cash balance was $41,496 as compared to $51,965 at December 31, 2016. Our plan for satisfying our cash requirements for the next twelve months is through the sale of shares of our common stock, third party financing, and/or traditional bank financing. We do not anticipate generating sufficient amounts of revenues to meet our working capital requirements. Consequently, we intend to make appropriate plans to ensure sources of additional capital in the future to fund growth and expansion through additional equity or debt financing or credit facilities.

For the Year Ended December 31, 2016

At December 31, 2016, we had total current assets of $138,054 consisting of $51,965 in cash and cash equivalents, accounts receivables of $1,454 and inventory of $84,635. Current liabilities at December 31, 2016 were $3,276 and consisted of $0 in accounts payable and $3,276 in royalty payable to Mr. Bachmann. At December 31, 2016, we had working capital of $134,778.

During the year ended December 31, 2016, we used $41,278 in cash in our operating activities. A net loss of $78,912 for the period was reconciled by such non-cash items as $24,670 in depreciation, $17,989 in accounts receivable, and $2,413 in royalty payable to Mr. Bachmann. Nothing was due to related parties at December 31, 2016.

 12

During the year ended December 31, 2015, we used $39,811 in our operating activities. A net loss of $54,213 was reconciled for such non-cash items as $16,041 in depreciation and $13,666 in inventory.

During the year ended December 31, 2016, we used $63,169 in investing activities. During the year ended December 31, 2015, we used $0 in investing activities.

During the year ended December 31, 2016, $0 was received from financing activities compared to $79,000 through a private placement during the year ended December 31, 2015. During the year ended December 31, 2016, we issued 0 shares of our restricted common stock, compared to 790,000 shares during the year ended December 31, 2015. During the years ended December 31, 2016 and 2015, we issued $0 in convertible promissory notes.

Amounts owed in accounts payable totaled $(1,958) and $0, royalty payable totaled $2,413 and $26, and amount due to related parties of $0 and $(15,000) as of December 31, 2016 and 2015, respectively.

The board of directors approved and granted Jarrold R. Bachmann an officer and shareholder, a $1.20 per case royalty on sales of Pocket Shot effective January 1, 2006. Royalty expense for the years ending December 31, 2016 and 2015 were $2,412 and $2,957 respectively.

Going Concern

We have only a very limited amount of cash and have incurred operating losses and limited cash flows from operations since inception. As of September 30, 2017 and December 31, 2016, we had retained deficit of $399,730 and $367,721 respectively and we will require additional working capital to fund operations through 2017 and beyond. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our financial statements included in this Form 10-Q do not include any adjustments related to recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern. The audited financial statements included in the Company’s recent annual report on Form 10-K have been prepared assuming that we will continue as a going concern and do not include any adjustments that might result if we cease to continue as a going concern.

Based on our financial history since inception, in their report on the financial statements for the period ended December 31, 2016, our independent registered public accounting firm has expressed substantial doubt as to our ability to continue as a going concern. There is no assurance that any revenue will be realized in the future.

There can be no assurance that we will have adequate capital resources to fund planned operations or that any additional funds will be available to us when needed or at all, or, if available, will be available on favorable terms or in amounts required by us. If we are unable to obtain adequate capital resources to fund operations, we may be required to delay, scale back or eliminate some or all of our operations, which may have a material adverse effect on our business, results of operations and ability to operate as a going concern.

Short Term

On a short-term basis, we have not generated revenues sufficient to cover our growth oriented operations plan. Based on prior history, we may continue to incur losses until such a time that our revenues are sufficient to cover our operating expenses and growth oriented operations plan. As a result we may need additional capital in the form of equity or loans, none of which is committed as of this filing.

Capital Resources

We have only common stock as our capital resource, and our assets, cash and receivables.

We have no material commitments for capital expenditures within the next year, however, as operations are expanded substantial capital will be needed to pay for expansion and working capital.

 13

Need for Additional Financing

We do not have capital sufficient to meet our growth plans. We have made equity and debt offerings in order to support our growth plans, to date, and may do so in the future.

No commitments to provide additional funds have been made by our management or other stockholders. Accordingly, there can be no assurance that any additional funds will be available to us to allow coverage of our expenses as they may be incurred.

Off Balance Sheet Arrangements

None

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is accumulated and communicated to management including our principal executive officer and principal financial officer as appropriate, to allow timely decisions regarding required disclosure.

Management has carried out an evaluation of the effectiveness of the design and operation of our company’s disclosure controls and procedures. Due to the lack of personnel and outside directors, management acknowledges that there are deficiencies in these controls and procedures.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) or 15d-15(f)) during the quarter ended September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 14

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Not Applicable to Smaller Reporting Companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.

31.1	Certification of Chief Executive Officer and Acting Chief Financial Officer Pursuant to Rule 13a–14(a) or 15d-14(a) of the Securities Exchange Act of 1934
32.1	Certification of Chief Executive Officer and Acting Chief Financial Officer under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document (1)
101.SCH	XBRL Taxonomy Extension Schema Document (1)
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (1)
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document (1)
101.LAB	XBRL Taxonomy Extension Label Linkbase Document (1)
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document (1)

(1) Pursuant to Rule 406T of Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 15

SIGNATURES

Pursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

THE POCKET SHOT COMPANY

(Registrant)

Dated: November 17, 2017	By:	/s/ Jarrold Bachmann
		Jarrold Bachmann
		(Chief Executive Officer, Principal Executive
		Officer, Acting Chief Financial Officer
		and Principal Accounting Officer)

 16

EX-31.1

EXHIBIT 31.1

SECTION 302 CERTIFICATION

EXHIBIT 31.1

CERTIFICATION OF PERIODIC REPORT

I, Jarrold Bachmann, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Pocket Shot Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. As the registrant’s sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s 4th quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. As the registrant’s certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 17, 2017

/s/ Jarrold Bachmann

Jarrold Bachmann

(Chief Executive Officer, Principal Executive Officer and Chief Financial Officer, Principal Accounting Officer)

EX-32.1

EXHIBIT 32.1

SECTION 906 CERTIFICATION

Exhibit 32.1

CERTIFICATION OF DISCLOSURE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of The Pocket Shot Company (the “Company”) on Form 10-Q for the period ending September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) I, Jarrold Bachmann, Chief Executive Officer, Principal Executive Officer, Chief Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 USC Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 17, 2017

/s/ Jarrold Bachmann

Jarrold Bachmann (Chief Executive Officer, Principal

Executive Officer,

Chief Financial Officer and Principal Accounting Officer)

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 15, 2017
Document And Entity Information
Entity Registrant Name	Pocket Shot Co
Entity Central Index Key	0001351573
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,458,657
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2017

XML

Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash	$ 41,496	$ 51,965
Accounts receivable	4,545	1,454
Inventory	73,396	84,635
Total current assets	119,437	138,054
Fixed assets
Machinery & equipment	305,165	305,165
Accumulated depreciation	(246,138)	(224,595)
Total fixed assets	59,027	80,570
Total assets	178,464	218,624
Current liabilities
Accounts payable	13,194
Royalty payable	5,077	3,276
Total current liabilities	18,271	3,276
Stockholders' equity
Common stock, no par value, 6,458,657 shares issued and outstanding at September 30, 2017 and December 31, 2016
Additional paid-in capital	583,069	583,069
Retained deficit	(422,876)	(367,721)
Total Stockholders' equity	160,193	215,348
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 178,464	$ 218,624

XML

Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, no par value
Common stock, shares issued	6,458,657	6,458,657
Common stock, shares outstanding	6,458,657	6,458,657

XML

Income Statements - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Royalty income	$ 24,673	$ 20,412	$ 62,114	$ 72,485
Costs of sales	8,418	605	20,912	20,331
Gross margin	16,255	19,807	41,202	52,154
Operating expenses
Advertising and promotion		255	319	5,805
General and administrative expenses	31,477	18,592	69,483	67,800
Sales incentives				832
Travel and entertainment	755	2,949	5,012	7,826
Depreciation expense	7,169	8,225	21,543	17,670
Total costs and expenses	39,401	30,021	96,357	99,933
Net income (loss)	$ (23,146)	$ (10,214)	$ (55,155)	$ (47,779)

XML

Statements of Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Stockholders' Deficit [Member]	Total
Balance at Dec. 31, 2013		$ 497,500	$ (165,818)	$ 331,682
Balance, shares at Dec. 31, 2013	5,668,657
Net loss			(68,778)	(68,778)
Balance at Dec. 31, 2014		497,500	(234,596)	262,904
Balance, shares at Dec. 31, 2014	5,668,657
Shares issued for cash		79,000		79,000
Shares issued for cash, shares	790,000
Net loss			(54,213)	(54,213)
Balance at Dec. 31, 2015		583,069	(288,809)	294,260
Balance, shares at Dec. 31, 2015	6,458,657
Net loss			(78,912)	(78,912)
Balance at Dec. 31, 2016		583,069	(367,721)	215,348
Balance, shares at Dec. 31, 2016	6,458,657
Net loss			(55,155)	(55,155)
Balance at Sep. 30, 2017		$ 583,069	$ (422,876)	$ 160,193
Balance, shares at Sep. 30, 2017	6,458,657

XML

Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows provided by operating activities:
Net loss	$ (55,155)	$ (47,779)
Changes in Operating Assets and Liabilities
Accounts Receivable	(3,091)	11,930
Inventory	11,239	(7,804)
Accounts payable	13,194	(1,958)
Royalty payable	1,801	2,102
Depreciation	21,543	17,670
Net cash provided (used) by operating activities	(10,469)	(25,839)
Cash flows from investing activities:
Purchases of property and equipment		(83,169)
Net cash used by investing activities		(83,169)
Cash flows from financing activities
Issuance of Capital Stock for cash
Net cash provided by financing activities
Net increase (decrease) in cash	(10,469)	(109,008)
Cash, beginning of period	51,965	156,412
Cash end of period	$ 41,496	$ 47,404

XML

Organization and Description of Business

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Organization and Description of Business

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

The Pocket Shot Company, formerly Pocket Shot, LLC, a Colorado limited liability company, was initially formed on April 18, 2004. Under a 351 Exchange Agreement, the members chose to contribute all of their membership interests in the LLC to The Pocket Shot Company, a Colorado corporation in exchange for shares of common stock of the corporation in accordance with the terms and provisions of the agreement. The effective date for the exchange was January 1, 2006. The Company has developed a plastic pouch for the packaging of alcohol under the trademarks Pocketshot and Pocket Shot. The Company collects royalty income from licensing the right to use the patent and the trademarks in connection with manufacturing, filling and packaging the pouches with alcohol and the distribution, sale and advertising of the products under the brand name.

The Company’s accounting year end is December 31.

Basis of Presentation

These financial statements are presented in United States dollars and have been prepared in accordance with United States generally accepted accounting principles.

Management’s Representation of Interim Financial Statements

The accompanying unaudited financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These financial statements should be read in conjunction with the audited financial statements at December 31, 2015 and December 31, 2016 as presented in the Company’s Registration statement on Form S-1 filed with the Securities and Exchange Commission.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative instruments and recorded debt discount, valuation of deferred tax assets and valuation of in-kind contribution of services and interest.

Cash and Cash Equivalents

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At September 30, 2017 and December 31, 2016, the Company cash equivalents totaled $41,496 and $51,965 respectively.

Accounts Receivable

We record accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the combined statements of operations. We calculate this allowance based on our history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and our relationships with, and the economic status of, our customers. As of December 31, 2015 and December 31, 2016, an allowance for estimated, uncollectible accounts was determined to be unnecessary.

Inventory

Inventory is reported at the lower of cost or market on the first-in, first-out (FIFO) method. Our inventory is subject to obsolescence. Accordingly, quantities on hand are periodically monitored for items no longer being sold, which are written off. All inventory is stored at the manufacturer and maintained by them. Inventory consists of pouches, display and shipping boxes and no inventory is deemed obsolete.

Machinery and Equipment

Machinery and equipment is recorded at cost. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant machinery and equipment categories are as five years.

A summary of machinery and equipment as of September 30, 2017 and December 31, 2016, is as follows:

	2017			2016
Machinery and equipment	$	305,165		$	305,165
Less accumulated depreciation		(246,138	)		(224,595	)
	$	59,027		$	80,570

Depreciation expense for the nine months ended September 30, 2017 and 2016 was $21,543 and $17,670, respectively.

Cost of Sales

The costs associated with our royalty income are packaging, a royalty of $1.20 per case, and repair and maintenance costs of our filling machines.

Advertising and Promotion

This category includes costs of website design and maintenance and event sponsorships.

General and Administrative

This category includes costs of legal and accounting, telephone, office supplies, product samples, insurance, registration costs, and consulting expenses.

Travel and Entertainment

This category includes the costs of air travel, hotels, meals and reimbursed automotive expenses.

Net Loss per Share

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share”. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

Revenue Recognition

We recognize revenue when the four revenue recognition criteria are met, as follows:

● Persuasive evidence of an arrangement exists – our customary practice is to obtain written evidence, typically in the form of a sales contract or purchase order;

● Delivery – when custody is transferred to our customers either upon shipment to or receipt at our customers’ locations, with no right of return or further obligations, such as installation;

● The price is fixed or determinable – prices are typically fixed at the time the order is placed and no price protections or variables are offered; and

● Collectability is reasonably assured – we typically work with businesses with which we have a long standing relationship, as well as monitoring and evaluating customers’ ability to pay.

Refunds and returns, which are minimal, are recorded as a reduction of revenue. Payments received by customers prior to our satisfying the above criteria are recorded as unearned income in the combined balance sheets.

Fair Value of Financial Instruments

The Company applies the accounting guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, “Fair Value Measurements”, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.

The guidance also establishes a fair value hierarchy for measurements of fair value as follows:

● Level 1 - quoted market prices in active markets for identical assets or liabilities.

● Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

● Level 3 - unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amount of the Company’s financial instruments approximates their fair value as of September 30, 2017 and December 31, 2016, due to the short-term nature of these instruments.

Recent Accounting Pronouncements

All newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

XML

Related Party Transaction

9 Months Ended

Sep. 30, 2017

Related Party Transactions [Abstract]

Related Party Transaction

NOTE 3 – RELATED PARTY TRANSACTION

Consulting services are provided by shareholders. For the nine months ended September 30, 2017 and 2016, fees for these services amounted to $0 and $24,000 respectively.

The board of directors has approved and granted Jarrold R. Bachmann an officer and shareholder, a $1.20 per case royalty on sales of Pocket Shot effective January 1, 2006. Royalty expense for the nine months ended September 30, 2017 and 2016 were $1,801 and $2,102 respectively.

XML

Stockholders' Deficit

9 Months Ended

Sep. 30, 2017

Equity [Abstract]

Stockholders' Deficit

NOTE 4 – STOCKHOLDERS’ DEFICIT

The company has authorized and issued 6,458,657 common shares with a par value of $0.00 as of September 30, 2017 and December 31, 2016.

Under a 351 Exchange Agreement effective January 1, 2006, the former members of Pocket Shot, LLC agreed to contribute all of their membership interests in the LLC to The Pocket Shot Company, a Colorado corporation, in exchange for 4,943,657 shares of common stock, no par value per share, of the corporation in accordance with the terms and provisions of the agreement. Upon approval of the board of directors, the corporation has subsequently issued 675,000 shares of common stock at $0.50 per share and warrants to purchase 675,000 shares of common stock for $1 per share. The warrants have expired unexercised.

On June, 22, 2009, the board of directors approved the issuance of 50,000 shares of common stock to Michael Grove in consideration of past services as the Corporation’s consulting accountant.

In September, 2015, the company issued 790,000 common shares with a par value of $0.00 in exchange for $79,000.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2017

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 5 – COMMITMENTS AND CONTINGENCIES

The Company has developed a plastic pouch for the packaging of alcohol under the marks Pocketshot and Pocket Shot. The Company (the Licensor) entered into an initial agreement dated August 10, 2005 with Frank-Lin Distillers, Ltd (the Licensee) to fill and package the Company’s product. The initial term of the agreement was for five years. The agreement automatically renews for succeeding terms of two years each unless either party has given a written notice of its election to terminate the agreement at least one hundred, eighty calendar days prior to the end of any initial or extended term.

XML

Royalty Income

9 Months Ended

Sep. 30, 2017

Royalty Income

Royalty Income

NOTE 6 – ROYALTY INCOME

Under the terms of an existing License agreement, the company receives Royalty income in exchange for the license to manufacture, fill and distribute the Company’s product, a plastic pouch for the packaging of alcohol. The Licensee is required to pay the Licensor a royalty per case as provided in the agreement. All royalties due to the Licensor shall accrue upon the sale of the products, regardless of the time of collection by the Licensee.

XML

Concentration of Sales and Segmented Disclosure

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Concentration of Sales and Segmented Disclosure

NOTE 7 – CONCENTRATION OF SALES AND SEGMENTED DISCLOSURE

For the nine months ended September 30, 2017 and the year ended December 31, 2016, the company’s revenue was generated in the form of royalty income from a single license agreement. The company has operated in a single business segment, licensing their product to customers in the United States.

XML

Warrants

9 Months Ended

Sep. 30, 2017

Warrants

Warrants

NOTE 8 – WARRANTS

In August 2015, the Company offered 790,000 shares of common stock at $0.10 per share, which included 790,000 warrants (1-for-1) exercisable at $0.50 per share of common stock, all expired in August 2017 unexercised. A summary of warrant activity is as follows:

	September 30, 2017				December 31, 2016
	Shares		Exercise Price		Shares		Exercise Price
Outstanding, beginning of period		6,458,657		N/A		6,458,657		N/A
Warrants Issued		0		N/A		0		N/A
Warrants Exercised		0		N/A		0		N/A
Warrants Expired		6,458,657		N/A		0		N/A
Outstanding, end of period		0		N/A		6,458,657		N/A

The fair value of the Warrants, $6,569, has been determined using the Black Scholes model with the following assumptions: stock price of $0.10 based on current sales of stock for cash, an exercise price of $.50 based on the agreement, term of 2 years, volatility of 81% based on comparable public companies, annual rate of quarterly dividends of 0.0% and a discount rate of 0.75 which resulted in a call option value of $0.01 per warrant.

XML

Subsequent Events

9 Months Ended

Sep. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

NOTE 9 – SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the filing date of these financial statements and has disclosed that there are no such events that are material to the financial statements to be disclosed.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Use of Estimates

Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment, estimate of fair value of share based payments and derivative instruments and recorded debt discount, valuation of deferred tax assets and valuation of in-kind contribution of services and interest.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At September 30, 2017 and December 31, 2016, the Company cash equivalents totaled $41,496 and $51,965 respectively.

Accounts Receivable

Accounts Receivable

We record accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances and is charged to other income (expense) in the combined statements of operations. We calculate this allowance based on our history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and our relationships with, and the economic status of, our customers. As of December 31, 2015 and December 31, 2016, an allowance for estimated, uncollectible accounts was determined to be unnecessary.

Inventory

Inventory

Inventory is reported at the lower of cost or market on the first-in, first-out (FIFO) method. Our inventory is subject to obsolescence. Accordingly, quantities on hand are periodically monitored for items no longer being sold, which are written off. All inventory is stored at the manufacturer and maintained by them. Inventory consists of pouches, display and shipping boxes and no inventory is deemed obsolete.

Machinery and Equipment

Machinery and Equipment

Machinery and equipment is recorded at cost. Expenditures for major additions and improvements are capitalized and minor replacements, maintenance, and repairs are charged to expense as incurred. When property and equipment is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in the results of operations for the respective period. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally accelerated) for tax purposes where appropriate. The estimated useful lives for significant machinery and equipment categories are as five years.

A summary of machinery and equipment as of September 30, 2017 and December 31, 2016, is as follows:

	2017			2016
Machinery and equipment	$	305,165		$	305,165
Less accumulated depreciation		(246,138	)		(224,595	)
	$	59,027		$	80,570

Depreciation expense for the nine months ended September 30, 2017 and 2016 was $21,543 and $17,670, respectively.

Cost of Sales

Cost of Sales

The costs associated with our royalty income are packaging, a royalty of $1.20 per case, and repair and maintenance costs of our filling machines.

Advertising and Promotion

Advertising and Promotion

This category includes costs of website design and maintenance and event sponsorships.

General and Administrative

General and Administrative

This category includes costs of legal and accounting, telephone, office supplies, product samples, insurance, registration costs, and consulting expenses.

Travel and Entertainment

Travel and Entertainment

This category includes the costs of air travel, hotels, meals and reimbursed automotive expenses.

Net Loss Per Share

Net Loss per Share

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by Financial Accounting Standards, ASC Topic 260, “Earnings per Share”. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

Revenue Recognition

Revenue Recognition

We recognize revenue when the four revenue recognition criteria are met, as follows:

● Persuasive evidence of an arrangement exists – our customary practice is to obtain written evidence, typically in the form of a sales contract or purchase order;

● Delivery – when custody is transferred to our customers either upon shipment to or receipt at our customers’ locations, with no right of return or further obligations, such as installation;

● The price is fixed or determinable – prices are typically fixed at the time the order is placed and no price protections or variables are offered; and

● Collectability is reasonably assured – we typically work with businesses with which we have a long standing relationship, as well as monitoring and evaluating customers’ ability to pay.

Refunds and returns, which are minimal, are recorded as a reduction of revenue. Payments received by customers prior to our satisfying the above criteria are recorded as unearned income in the combined balance sheets.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company applies the accounting guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, “Fair Value Measurements”, as well as certain related FASB staff positions. This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.

The guidance also establishes a fair value hierarchy for measurements of fair value as follows:

● Level 1 - quoted market prices in active markets for identical assets or liabilities.

● Level 2 - inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

● Level 3 - unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amount of the Company’s financial instruments approximates their fair value as of September 30, 2017 and December 31, 2016, due to the short-term nature of these instruments.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

All newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Schedule of Machinery and Equipment

A summary of machinery and equipment as of September 30, 2017 and December 31, 2016, is as follows:

	2017			2016
Machinery and equipment	$	305,165		$	305,165
Less accumulated depreciation		(246,138	)		(224,595	)
	$	59,027		$	80,570

XML

Warrants (Tables)

9 Months Ended

Sep. 30, 2017

Warrants

Summary of Warrant Activity

A summary of warrant activity is as follows:

	September 30, 2017				December 31, 2016
	Shares		Exercise Price		Shares		Exercise Price
Outstanding, beginning of period		6,458,657		N/A		6,458,657		N/A
Warrants Issued		0		N/A		0		N/A
Warrants Exercised		0		N/A		0		N/A
Warrants Expired		6,458,657		N/A		0		N/A
Outstanding, end of period		0		N/A		6,458,657		N/A

XML

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015
Accounting Policies [Abstract]
Cash and cash equivalents	$ 41,496	$ 47,404	$ 51,965	$ 156,412
Property, plant and equipment, depreciation methods	straight-line method
Estimated useful lives for machinery and equipment	5 Years
Machinery and equipment, depreciation expense	$ 21,543	$ 17,670
Cost of royalty income packing, per case	$ 1.20

XML

Summary of Significant Accounting Policies - Schedule of Machinery and Equipment (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Machinery and equipment	$ 305,165	$ 305,165
Less accumulated depreciation	(246,138)	(224,595)
Machinery and equipment, Net	$ 59,027	$ 80,570

XML

Related Party Transaction (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Jan. 01, 2006
Consulting services fees	$ 0	$ 24,000
Royalty expense	$ 1,801	$ 2,102
Jarrold R. Bachmann [Member]
Royalty per case			$ 1.20

XML

Stockholders' Deficit (Details Narrative) - USD ($)	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2015	Aug. 31, 2015	Jun. 22, 2009	Jan. 01, 2006
Common stock, shares authorized	6,458,657	6,458,657
Common stock, shares issued	6,458,657	6,458,657	790,000
Common stock, par value	$ 0.00	$ 0.00	$ 0.00
Common stock, no par value
Warrants to purchase, per share				$ 0.50
Common stock, issued value			$ 79,000
Founding Members [Member]
Common stock, shares issued						4,943,657
Board of Directors [Member]
Common stock, shares issued						675,000
Common stock, par value						$ 0.50
Warrants to purchase number of common stock						675,000
Warrants to purchase, per share						$ 1
Michael Grove [Member]
Common stock, shares issued					50,000

XML

Concentration of Sales and Segmented Disclosure (Details Narrative)	9 Months Ended
	Sep. 30, 2017 Number
Segment Reporting [Abstract]
Number of operating segments	1

XML

Warrants (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Aug. 31, 2015	Sep. 30, 2017
Stock issued during period, shares	790,000
Shares issued, price per share	$ 0.10
Number of warrants issued to purchase common stock	790,000
Warrants exercisable per share	$ 0.50
Warrant [Member]
Fair value of warrants		$ 6,569
Fair value assumptions, stock price		$ 0.10
Fair value assumptions, exercise price		$ .50
Fair value assumptions, term		2 years
Fair value assumptions, volatility		81.00%
Fair value assumptions, annual dividend rate		0.00%
Fair value assumptions, discount rate		0.75%
Fair value assumptions, call option value		$ 0.01

XML

Warrants - Summary of Warrant Activity (Details) - Warrant [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Outstanding, beginning of period	6,458,657	6,458,657
Warrants Issued	0	0
Warrants Exercised	0	0
Warrants Expired	6,458,657	0
Outstanding, end of period	0	6,458,657
Outstanding, beginning of period, exercise price
Warrants Issued, exercise price
Warrants Exercised, exercise price
Warrants Expired, exercise price
Outstanding, end of period, exercise price